THE REMEDY
In recent years, advanced biologic materials known as skin substitutes, or Cellular and Acellular Matrix Products (CAMPs), have transformed the landscape of wound care. Clinical evidence shows these products significantly improve healing rates and reduce complications compared to traditional approaches.
A 2020 systematic review in the Journal of Wound Care reported that biologic skin substitutes achieved markedly higher closure rates and faster healing times in diabetic foot ulcers than standard dressings. Similarly, a 2019 study in Advances in Wound Care highlighted their effectiveness in lowering infection risk and amputation rates.
What sets CAMPs apart is how they work. These biologic matrices create a scaffold in the wound bed that promotes tissue regeneration, supports new blood vessel growth, and provides the protective environment chronic wounds need to finally close. Unlike standard dressings that simply cover and manage, CAMPs actively stimulate the healing process.
For patients, this difference is life-changing. Faster healing means avoiding painful infections, reducing the risk of amputation, and regaining mobility and independence sooner. For providers, CAMPs deliver a reliable, evidence-based solution to a problem that has historically been one of medicine’s most frustrating challenges.
As one physician explained: “Studies have shown with our traditional wound care, we can only heal maybe 25% of wounds at the one-year mark. Other studies have shown over 90% healing at the two- or three-month mark with our skin substitutes.”
.jpg)
CAMPAIGN NAME
EXPERIENCED RESULTS
DRIVEN LEADERSHIP
2035